about
The geographic spread of the CCR5 Delta32 HIV-resistance alleleResistance to HIV InfectionGenomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practiceEstimation of 2Nes from temporal allele frequency data.Stochastic model of in-vivo X4 emergence during HIV infection: implications for the CCR5 inhibitor maraviroc.Distribution of the mutated delta 32 allele of CCR5 co-receptor gene in Iranian population.A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.CCR5 inhibitors: Emerging promising HIV therapeutic strategy.Distribution of CCR-5Δ32, CCR2-64I, and SDF-1-3'A alleles among Jordanians.Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats.Evaluation of the pharmacogenetics of immune recovery in treated HIV-infected patients.Potential Cancer Prevention and Treatment by Silencing the Killer Cell Immunoglobulin-like Receptor Gene in Natural Killer Cells Derived from Induced Pluripotent Stem Cells.Novel AIDS therapies based on gene editing.Analysis of CCR5 and SDF-1 genetic variants and HIV infection in Indian population.Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.A potential in vitro and in vivo anti-HIV drug screening system for Chinese herbal medicines.The Consequence of a Founder Effect: CCR5-∆32, CCR2-64I and SDF1-3'A Polymorphism in Vlach Gypsy Population in Hungary.Periodontal Infectogenomics.
P2860
Q21146086-3701ED07-858F-45CD-B913-9C2C8CFCBF9EQ27473466-5D5C67CC-0737-45D1-A2DC-E02216205E0EQ28543022-66212E00-1ABC-40EB-A49B-779A7DD4092DQ33336344-BF3A1816-9A94-491B-AA61-631B6EBC16D0Q34367158-8BCBE405-D2A1-48D6-AD92-AC3D8BDE8BD0Q35065655-B421A640-FCC7-465C-AC10-B666169A0771Q35191116-F37C4876-6DAE-4668-AA86-FAB2C075DAFCQ35199475-8DA2F195-AA4F-410C-AC23-CC99DC7033ADQ36509565-15BC66BA-2546-4208-A310-909CE1A129C1Q36761492-46C39FEE-9D69-421F-B27C-613347ECAEEDQ38164430-E8D5AB5C-1E94-4A2A-8F3C-60DA9575A351Q38790470-5F8CEFEB-0A69-4C2A-A4B7-D9F09181A873Q39140209-DE0558D4-32CF-43BE-9F27-22BF9D7F4DC2Q41147631-D82FA896-9A6C-453B-986E-C95D41A1F935Q42268944-2209617F-4AEF-4198-AB26-D95A27416090Q47316103-83559841-1469-4C68-B02D-0BC5E02BAC58Q54365147-4A49323B-8A7E-487C-BA89-30EEAB60AAE1Q55231820-C3511984-5435-4835-BBF7-76F924545FA0
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
HIV and the CCR5-Delta32 resistance allele
@ast
HIV and the CCR5-Delta32 resistance allele
@en
HIV and the CCR5-Delta32 resistance allele
@nl
type
label
HIV and the CCR5-Delta32 resistance allele
@ast
HIV and the CCR5-Delta32 resistance allele
@en
HIV and the CCR5-Delta32 resistance allele
@nl
prefLabel
HIV and the CCR5-Delta32 resistance allele
@ast
HIV and the CCR5-Delta32 resistance allele
@en
HIV and the CCR5-Delta32 resistance allele
@nl
P1476
HIV and the CCR5-Delta32 resistance allele
@en
P2093
Eric de Silva
Michael P H Stumpf
P356
10.1016/J.FEMSLE.2004.09.040
P407
P577
2004-12-01T00:00:00Z